<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Your Company</title>

  <!-- Tipografía moderna -->
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@300;500;700&display=swap" rel="stylesheet">
  
  <!-- CSS externo -->
  <link rel="stylesheet" href="styles.css">
</head>
<body>

  <!-- MENÚ SUPERIOR -->
  <header>
    <img src="logo-removebg-preview.png" alt="Company Logo" />

    <!-- Botón hamburguesa para móviles -->
    <div class="menu-toggle" id="menu-toggle">
      <span></span>
      <span></span>
      <span></span>
    </div>

    <nav>
      <ul id="nav-list">
        <li><a href="#home">Home</a></li>
        <li><a href="#OurPurpose">Our Purpose</a></li>
        <li><a href="#product">Our Product</a></li>
        <li><a href="#indications">Therapeutic Indications</a></li>
        <li><a href="#team">Our Team</a></li>
      </ul>
    </nav>
  </header>

  <!-- HOME — Hero Apple Style -->
  <section id="home" class="home-hero fade-in">
    <div class="hero-content">
      <h1>Taking innovation beyond the limits of cancer</h1>
    </div>
    <div class="hero-image">
      <img src="home.jpg" alt="Hero Image">
    </div>
  </section>

  <!-- OUR PURPOSE -->
  <section id="OurPurpose" class="fade-in">
    <h1>OUR PURPOSE</h1>
    <div class="card-container">
      <div class="card">
        <h2>MISSION</h2>
        <p>Develop an innovative immunotherapy for orphan indications with limited treatment options.</p>
      </div>
      <div class="card">
        <h2>VISION</h2>
        <p>Become a leading next-generation immunotherapy startup, advancing smart and localized treatments for orphan tumors.</p>
      </div>
      <div class="card">
        <h2>VALUES</h2>
        <ul>
          <li><strong>Scientific innovation:</strong> cutting-edge technology</li>
          <li><strong>Rigor and transparency:</strong> solid evidence</li>
          <li><strong>Commitment to patients:</strong> safety and quality of life</li>
          <li><strong>Collaboration:</strong> partners and investors</li>
        </ul>
      </div>
    </div>
  </section>

  <!-- OUR PRODUCT -->
  <section id="product" class="fade-in">
    <h1>OUR PRODUCT</h1>
    <div class="product-container">
      <p>
        Tumor cells frequently suppress anti-tumor immunity through PD-1/PD-L1 signaling, which leads to T-cell exhaustion and reduced cytotoxic activity. Our therapeutic strategy is designed to interfere with this pathway while simultaneously enhancing local immune activation within the tumor microenvironment.
      </p>
      <p>
        To achieve this, we engineer a nanobody with high affinity for the target immune checkpoint and fuse it to IL-12, a cytokine known to promote T-cell and NK-cell activation. This modular design aims to concentrate immune stimulation at the tumor site rather than systemically.
      </p>
      <p>
        The intended outcome is a dual-mechanism immunotherapy capable of restoring T-cell function, promoting local immune infiltration, and potentially reducing systemic toxicity compared with conventional checkpoint inhibitors.
      </p>
    </div>
  </section>

  <!-- THERAPEUTIC INDICATIONS -->
  <section id="indications" class="fade-in">
    <h1>THERAPEUTIC INDICATIONS</h1>
    <div class="indications-container">
      <p>Our development focuses on solid tumors characterized by immune evasion and limited response to existing immunotherapies.</p>
      <p>
        <li><strong>Head and neck squamous cell carcinoma (HNSCC):</strong> These tumors frequently display immunosuppressive microenvironments with high PD-L1 expression and T-cell dysfunction, making them suitable for therapies that both block immune checkpoints and enhance local cytokine signaling.</li>
      </p>
      <p>
        <li><strong>Malignant pleural mesothelioma (MPM):</strong> This cancer is typically resistant to current immunotherapeutic approaches due to low basal immune infiltration. A targeted cytokine-checkpoint fusion may help convert this “cold” microenvironment into an immune-responsive state.</li>
      </p>
      <p>By prioritizing indications with high unmet clinical need and clear immunological rationale, we aim to deliver therapeutics capable of producing meaningful clinical benefit while establishing a strong foundation for future expansion into broader oncology settings.</p>
    </div>
  </section>

  <!-- OUR TEAM -->
  <section id="team" class="fade-in">
    <h1>OUR TEAM</h1>
    <div class="team-grid">
      <div class="team-member">
        <img src="Ana.jpeg" alt="Ana Rodriguez">
        <h4>ANA RODRIGUEZ</h4>
        <p>Direction marketing and communication</p>
        <p>CEO & CMO</p>
      </div>
      <div class="team-member">
        <img src="Carlos.jpeg" alt="Carlos Tur">
        <h4>CARLOS TUR</h4>
        <p>Finances</p>
        <p>CFO</p>
      </div>
      <div class="team-member">
        <img src="Carla.jpeg" alt="Carla Gracia">
        <h4>CARLA GRACIA</h4>
        <p>Preclinical investigation</p>
        <p>CSO</p>
      </div>
      <div class="team-member">
        <img src="Alejandro.JPG" alt="Alejandro de Udaeta">
        <h4>ALEJANDRO DE UDAETA</h4>
        <p>Clinical development</p>
        <p>CSO</p>
      </div>
      <div class="team-member">
        <img src="Jade.jpeg" alt="Jade Begerano">
        <h4>JADE BEGERANO</h4>
        <p>Galenics and production</p>
        <p>CMC</p>
      </div>
      <div class="team-member">
        <img src="Angel.jpeg" alt="Angel Matesanz">
        <h4>ANGEL MATESANZ</h4>
        <p>Regulatory</p>
        <p>Head of Regulatory Affairs</p>
      </div>
    </div>
  </section>

  <!-- FOOTER -->
  <footer>
    © 2025 INTER12 SOLUTIONS — All rights reserved.
  </footer>

  <!-- SCRIPT: Animación scroll + menú desplegable -->
  <script>
    // Animación scroll
    const elements = document.querySelectorAll('.fade-in, .card, .product-section, .team-grid');
    const showOnScroll = () => {
      const triggerBottom = window.innerHeight * 0.85;
      elements.forEach(el => {
        const top = el.getBoundingClientRect().top;
        if(top < triggerBottom) el.classList.add('visible');
      });
    };
    window.addEventListener('scroll', showOnScroll);
    showOnScroll();

    // Menú desplegable móvil
    const toggle = document.getElementById('menu-toggle');
    const navList = document.getElementById('nav-list');
    toggle.addEventListener('click', () => {
      navList.classList.toggle('show');
    });
  </script>

</body>
</html>


